Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Appian Corp (APPN) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Appian CorpTrade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Appian Corp vs Marsh & McLennan Companies, Inc. — how do they compare? Appian Corp trades at $34.14 (market cap $2.54B), while Marsh & McLennan Companies, Inc. trades at $188.74 (market cap $91.27B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 35.9× Appian Corp's market cap, and Marsh & McLennan Companies, Inc. pays a 2.07% dividend while Appian Corp pays none. Which is the better fit depends on your goals.

APPNMRSH
Market Cap
$2.54B$91.27B
Sector
TechnologyFinancials
52-Week High
$45.64$211.21
52-Week Low
$18.72$157.32
Enterprise Value
$2.67B$111.95B
Dividend Yield
2.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Appian Corp

Appian Corporation (APPN) trades at $35.05, down 1.49% on the day, following a series of recent earnings beats. The stock exhibits a bullish technical trend with strong moving average support, though oscillators signal overbought conditions. Fundamentally, the company shows robust revenue growth, reaching $727 million in 2025, and has achieved positive net income after years of losses, yet maintains a negative shareholder equity position. Recent news highlights strategic AI partnerships and strong quarterly performance.

The outlook is cautiously optimistic, driven by AI-driven demand and enterprise growth, but significant risks persist, including high valuation multiples, negative equity, and intense competition. Analyst consensus is mixed, with a majority Hold rating, suggesting the stock may be fully valued near-term despite operational improvements.

Marsh & McLennan Companies, Inc.

Marsh & McLennan (MRSH) trades at $190.79, down 0.45% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat estimates with EPS of $2.96 versus $2.88 expected, driven by 6% revenue growth. The company announced the acquisition of Accel to expand Midwest operations, enhancing its insurance and consulting services. Valuation metrics show a P/E of 23.35 and ROE of 25.72%, reflecting robust profitability.

Outlook remains positive with a consensus price target of $202.89, offering ~6% upside. Risks include margin pressure from rising expenses and soft P&C pricing. Institutional activity is mixed, with Bank of America reducing its stake while others like Ashton Thomas Securities added positions. The stock presents a growth opportunity amid strategic expansions, though investors should monitor expense management and competitive dynamics.

Returns comparison

Trailing returns across standard periods

About Appian Corp

Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.

Read more on APPN

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH